WSI Co., Ltd. Logo

WSI Co., Ltd.

Develops, manufactures, and distributes pharmaceuticals and medical devices.

299170 | KO

Overview

Corporate Details

ISIN(s):
KR7299170001
LEI:
Country:
South Korea
Address:
서울특별시 송파구 삼학사로 47(삼전동) -, 서울특별시

Description

WSI Co., Ltd. is a healthcare company engaged in the development, manufacturing, and distribution of pharmaceuticals and medical devices. Founded in 2016, the company focuses on providing safe and technologically advanced products to improve health and well-being. Its portfolio includes a range of medical devices, with a specialization in solutions for spinal joints, as well as pharmaceuticals such as local hemostatic agents and blood substitutes. WSI leverages its professional expertise and a commitment to research and development to deliver innovative and competitive medical solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2025-09-04 00:00
주식등의대량보유상황보고서(일반)
Korean 98.3 KB
2025-09-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.0 KB
2025-08-29 00:00
주식등의대량보유상황보고서(일반)
Korean 115.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-08 00:00
주식등의대량보유상황보고서(약식)
Korean 71.1 KB
2025-08-07 00:00
[기재정정]전환청구권행사
Korean 16.8 KB
2025-08-07 00:00
[기재정정]전환청구권행사
Korean 16.8 KB
2025-08-04 00:00
주식등의대량보유상황보고서(약식)
Korean 66.1 KB
2025-07-30 00:00
전환가액의조정
Korean 16.1 KB
2025-07-29 00:00
전환청구권행사
Korean 13.9 KB
2025-06-16 00:00
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
Korean 91.8 KB
2025-06-12 00:00
전환청구권행사
Korean 10.6 KB
2025-06-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-06-02 00:00
전환청구권행사
Korean 10.4 KB

Automate Your Workflow. Get a real-time feed of all WSI Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WSI Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WSI Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.